This Article Full Text Full Text (PDF) All Versions of this Article: 107/9/1315    most recent 01.CIR.0000054781.50889.0Cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lieu, H. D. Articles by Young, S. G. Search for Related Content PubMed PubMed Citation Articles by Lieu, H. D. Articles by Young, S. G. Related Collections Animal models of human disease Pathophysiology Gene expression Genetically altered mice Lipid and lipoprotein metabolism

(Circulation. 2003;107:1315.)
© 2003 American Heart Association, Inc.

Basic Science Reports

Eliminating Atherogenesis in Mice by Switching Off Hepatic Lipoprotein Secretion

Hsiao D. Lieu, MD; Shannon K. Withycombe, BS; Quinn Walker, BS; James X. Rong, PhD; Rosemary L. Walzem, PhD; Jinny S. Wong, MA; Robert L. Hamilton, PhD; Edward A. Fisher, MD, PhD; Stephen G. Young, MD

From the Gladstone Institute of Cardiovascular Disease (H.D.L., S.K.W., Q.W., S.G.Y.); the Cardiovascular Research Institute, University of California, San Francisco (H.D.L., S.G.Y., J.S.W., R.L.H.); the Department of Medicine, University of California, San Francisco (H.D.L., S.G.Y.); and the Department of Anatomy, University of California, San Francisco (R.L.H.), San Francisco, Calif; the Poultry Science Department, Texas A&M University, College Station, Tex (R.L.W.); and the Cardiovascular Institute and Department of Medicine, Mount Sinai School of Medicine, New York, NY (J.X.R., E.A.F.).

Correspondence to Dr Hsiao D. Lieu, Gladstone Institute of Cardiovascular Disease, PO Box 419100, San Francisco, CA 94141-9100. E-mail hlieu{at}gladstone.ucsf.edu

Background— LDL receptor–deficient "apolipoprotein (apo)-B100–only" mice (Ldlr^-/-Apob^100/100 have elevated LDL cholesterol levels on a chow diet and develop severe aortic atherosclerosis. We hypothesized that both the hypercholesterolemia and the susceptibility to atherosclerosis could be eliminated by switching off hepatic lipoprotein production.

Methods and Results— We bred Ldlr^-/-Apob^100/100 mice that were homozygous for a conditional allele for Mttp (the gene for microsomal triglyceride transfer protein) and the inducible Mx1-Cre transgene. In these animals, which we called "Reversa mice," the hypercholesterolemia could be reversed, without modifying the diet or initiating a hypolipidemic drug, by the transient induction of Cre expression in the liver. After Cre induction, hepatic Mttp expression was virtually eliminated (as judged by quantitative real-time PCR), hepatic lipoprotein secretion was abolished (as judged by electron microscopy), and LDLs were virtually eliminated from the plasma. Intestinal lipoprotein production was unaffected. In mice fed a chow diet, Cre induction reduced plasma cholesterol levels from 233.9±46.0 to 37.2±6.5 mg/dL. In mice fed a high-fat diet, cholesterol levels fell from 525.7±32.2 to 100.6±14.3 mg/dL. The elimination of hepatic lipoprotein production completely prevented both the development of atherosclerosis and the changes in gene expression that accompany atherogenesis.

Conclusions— We developed mice in which hypercholesterolemia can be reversed with a genetic switch. These mice will be useful for understanding gene-expression changes that accompany the reversal of hypercholesterolemia and atherosclerosis.

Key Words: cholesterol • hypercholesterolemia • apolipoproteins • lipoproteins • atherosclerosis

This article has been cited by other articles:

				J. D. Miller, R. M. Weiss, K. M. Serrano, R. M. Brooks II, C. J. Berry, K. Zimmerman, S. G. Young, and D. D. Heistad Lowering Plasma Cholesterol Levels Halts Progression of Aortic Valve Disease in Mice Circulation, May 26, 2009; 119(20): 2693 - 2701. [Abstract] [Full Text] [PDF]

				J. Iqbal, L. L. Rudel, and M. M. Hussain Microsomal Triglyceride Transfer Protein Enhances Cellular Cholesteryl Esterification by Relieving Product Inhibition J. Biol. Chem., July 18, 2008; 283(29): 19967 - 19980. [Abstract] [Full Text] [PDF]

				A. Kovacs, P. Tornvall, R. Nilsson, J. Tegner, A. Hamsten, and J. Bjorkegren Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia PNAS, August 21, 2007; 104(34): 13768 - 13773. [Abstract] [Full Text] [PDF]

				W. Hsueh, E. D. Abel, J. L. Breslow, N. Maeda, R. C. Davis, E. A. Fisher, H. Dansky, D. A. McClain, R. McIndoe, M. K. Wassef, et al. Recipes for Creating Animal Models of Diabetic Cardiovascular Disease Circ. Res., May 25, 2007; 100(10): 1415 - 1427. [Abstract] [Full Text] [PDF]

				M. J. Graham, K. M. Lemonidis, C. P. Whipple, A. Subramaniam, B. P. Monia, S. T. Crooke, and R. M. Crooke Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic mice J. Lipid Res., April 1, 2007; 48(4): 763 - 767. [Abstract] [Full Text] [PDF]

				R. M. Weiss, M. Ohashi, J. D. Miller, S. G. Young, and D. D. Heistad Calcific Aortic Valve Stenosis in Old Hypercholesterolemic Mice Circulation, November 7, 2006; 114(19): 2065 - 2069. [Abstract] [Full Text] [PDF]

				N. J. Spann, S. Kang, A. C. Li, A. Z. Chen, E. P. Newberry, N. O. Davidson, S. T. Y. Hui, and R. A. Davis Coordinate Transcriptional Repression of Liver Fatty Acid-binding Protein and Microsomal Triglyceride Transfer Protein Blocks Hepatic Very Low Density Lipoprotein Secretion without Hepatosteatosis J. Biol. Chem., November 3, 2006; 281(44): 33066 - 33077. [Abstract] [Full Text] [PDF]

				K. Minehira-Castelli, S. W. Leonard, Q. M. Walker, M. G. Traber, and S. G. Young Absence of VLDL secretion does not affect {alpha}-tocopherol content in peripheral tissues J. Lipid Res., August 1, 2006; 47(8): 1733 - 1738. [Abstract] [Full Text] [PDF]

				P. Rava, G. K. Ojakian, G. S. Shelness, and M. M. Hussain Phospholipid Transfer Activity of Microsomal Triacylglycerol Transfer Protein Is Sufficient for the Assembly and Secretion of Apolipoprotein B Lipoproteins J. Biol. Chem., April 21, 2006; 281(16): 11019 - 11027. [Abstract] [Full Text] [PDF]

				D. D. Heistad Oxidative Stress and Vascular Disease: 2005 Duff Lecture Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 689 - 695. [Abstract] [Full Text] [PDF]

				Y. Xie, E. P. Newberry, S. G. Young, S. Robine, R. L. Hamilton, J. S. Wong, J. Luo, S. Kennedy, and N. O. Davidson Compensatory Increase in Hepatic Lipogenesis in Mice with Conditional Intestine-specific Mttp Deficiency J. Biol. Chem., February 17, 2006; 281(7): 4075 - 4086. [Abstract] [Full Text] [PDF]

				G. S. Getz and C. A. Reardon Diet and Murine Atherosclerosis Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 242 - 249. [Abstract] [Full Text] [PDF]

				R. M. Crooke, M. J. Graham, K. M. Lemonidis, C. P. Whipple, S. Koo, and R. J. Perera An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis J. Lipid Res., May 1, 2005; 46(5): 872 - 884. [Abstract] [Full Text] [PDF]

				J. Llodra, V. Angeli, J. Liu, E. Trogan, E. A. Fisher, and G. J. Randolph From the Cover: Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques PNAS, August 10, 2004; 101(32): 11779 - 11784. [Abstract] [Full Text] [PDF]

				S. M. S. Espirito Santo, N. M. M. Pires, L. S. M. Boesten, G. Gerritsen, N. Bovenschen, K. W. van Dijk, J. W. Jukema, H. M. G. Princen, A. Bensadoun, W.-P. Li, et al. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol Blood, May 15, 2004; 103(10): 3777 - 3782. [Abstract] [Full Text] [PDF]